NEWSBRIEF

NEWSBRIEF

Andrew von Eschenbach has been named acting commissioner of the US Food and Drug Administration following the resignation of former commissioner Lester Crawford last week.

Title: Nucleic Acid-Mediated Inhibition of Enterococcus Infection and Cytolysin Toxin Activity Number: 20050209182 Filed: Dec. 14, 2004 Lead Inventor: David Morrissey, Sirna Therapeutics

NEWSBRIEF

New Products GenTel BioSurfaces announced last week the launch of its Path HTS platform for high-throughput quantitative immunoassays.

Multiple lectin affinity columns, IPG strips, and MicroSol-Isoelectric Focusing were some of the less conventional approaches that were presented as ways of fractionating proteins and peptides before mass-spec analysis. Subscribers: click headline for more

NEWSBRIEF

Recent NIH Proetomics Awards in FY 2005* (L-Z)

GE Healthcare to Manufacture miRNA Arrays for Ambion on CodeLink Chips GE Healthcare will manufacture microRNA microarrays on its CodeLink platform for Ambion, the companies said today.

With help from a nonprofit consortium, some well-known academic centers, and a former employer, the company is trying to use siRNAs to develop therapeutics for pachyonychia congenita. Subscribers: click headline for more

NEWSALERT

Also noteworthy is that, unlike other prostate cancer research groups that use mass spec-based methods for biomarker discovery, the researchers developing the test used a protein array-based method to discover their panel of biomarkers. Subscribers: click headline for more

However, the approach faces significant hurdles, including the prerequisite to destroy a patient s existing stem cell population through radiation therapy -- a risky proposition for individuals with HIV because it could sap their already-weakened immune system. Subscribers: click headline for more

Cleveland Foundation Awards $1.5M to Case Proteomics Center The Cleveland Foundation said this week that it has awarded a three-year, $1.5 million grant to support the Case Proteomics Center at Case Western Reserve University's School of Medicine.

The deal could also help PerkinElmer gain better overall name recognition in cell-based screening, which could help its LumiLux platform gain market penetration more rapidly. Subscribers: click headline for more

NEWSBRIEF

Pairings Andrew von Eschenbach has been named acting commissioner of the US Food and Drug Administration, following the resignation of former commissioner Lester Crawford last week.

NEWSBRIEF

NEWSBRIEF

NEWSBRIEF

In the end, Oxford and GE hope to end up with lots of intellectual property to pour into diagnostics. Subscribers: click headline for more

NEWSBRIEF